Hemab Therapeutics Holdings, Inc. (COAG)
Nasdaq: COAG · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2026
Who runs Hemab Therapeutics Holdings, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Sorensen Benny
President and Chief Executive Officer 24.1 Power of Attorney. First filing Apr 2026, latest Apr 30, 2026, 0 filings in all.
Officers reporting now
4
of 15 people with a filing in the last fifteen months
Directors reporting now
11
15 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Behrndt-Eriksen Mads Nikolaj | Chief Financial Officer and General Manager | Apr 2026 | May 4, 2026 | none |
| Madigan Catherine | Chief Medical Officer | Apr 2026 | May 4, 2026 | none |
| Sorensen Benny | President and Chief Executive Officer 24.1 Power of Attorney | Apr 2026 | Apr 30, 2026 | none |
| Murthy Ananthram Sreenivasa | Chief Operating Officer | Apr 2026 | Apr 30, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Walbert Keli | director | Sep 2026 | Sep 25, 2026 | none |
| Kolchinsky Peter | director | Apr 2026 | Jun 17, 2026 | none |
| Ra Capital Healthcare Fund LP | director | Apr 2026 | Jun 17, 2026 | none |
| Ra Capital Management, L.P. | director | Apr 2026 | Jun 17, 2026 | none |
| Shah Rajeev M. | director | Apr 2026 | Jun 17, 2026 | none |
| Ra Capital Nexus Fund II, L.P. | director | Apr 2026 | May 6, 2026 | none |
| Ra Capital Nexus Fund IV, L.P. | director | Apr 2026 | May 6, 2026 | none |
| Maraganore John | director | Apr 2026 | May 4, 2026 | none |
| Bain Linda | director | Apr 2026 | Apr 30, 2026 | none |
| Tadvalkar Laura | director | Apr 2026 | Apr 30, 2026 | none |
| Vaishnaw Akshay | director | Apr 2026 | Apr 30, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Access Industries Holdings LLC | 10% owner | May 2026 | May 14, 2026 | none |
| Access Industries Management, LLC | 10% owner | May 2026 | May 14, 2026 | none |
| Ai Biotechnology LLC | 10% owner | May 2026 | May 14, 2026 | none |
| Ai Den-Mab LLC | 10% owner | May 2026 | May 14, 2026 | none |
| Blavatnik Len | 10% owner | May 2026 | May 14, 2026 | none |
| Novo Holdings A/s | 10% owner | Apr 2026 | May 6, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.